{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:05:32Z","timestamp":1790373932595,"version":"4.1.0"},"reference-count":43,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T00:00:00Z","timestamp":1676332800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Review"],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>The introduction of depot buprenorphine for the treatment of opioid dependence allows for reduced dosing frequency compared with conventional treatments, such as oral methadone and sublingual buprenorphine\u2010naloxone. Reduced dosing frequency is perceived to reduce issues such as high out\u2010of\u2010pocket costs, frequent attendance to pharmacies, stigmatisation and the risk of diversion for unsanctioned opioid use. This study aims to explore the experiences of patients receiving depot buprenorphine from an Australian publicly operated drug and alcohol service.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Participants were recruited from the service over a 5\u2010week period in 2021. Twenty\u2010eight participants consented to be involved in a mixed methods quantitative verbal survey and qualitative interview process.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The majority of participants reported satisfaction with depot buprenorphine across the domains of efficacy, convenience and global satisfaction. Participants perceived benefits as increased convenience, reduced stigmatisation and the inability to \u2018skip\u2019 daily Medication Assisted Treatment for Opioid Dependence (MATOD) doses. There were mixed experiences with the ability for depot buprenorphine to \u2018hold\u2019 participants throughout the dosing interval. Reduced contact and disconnection from healthcare services were reported as an issue for some participants when initiating depot buprenorphine.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion and Conclusions<\/jats:title><jats:p>Patient perceptions of depot buprenorphine appear to be deeply rooted in prior experience with \u2018conventional\u2019 MATOD treatments. Depot buprenorphine is seen to be beneficial socially, personally, and financially by the majority of patients interviewed. The potential for disconnection from services and mixed experiences of efficacy throughout the dosing period may negatively influence patient experience.<\/jats:p><\/jats:sec>","DOI":"10.1111\/dar.13616","type":"journal-article","created":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T04:14:31Z","timestamp":1676434471000},"page":"791-802","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Exploring patient experience and satisfaction with depot buprenorphine formulations: A mixed\u2010methods study"],"prefix":"10.1111","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8307-3429","authenticated-orcid":false,"given":"Eve","family":"Allen","sequence":"first","affiliation":[{"name":"UniSA Clinical and Health Sciences University of South Australia  Adelaide Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sona","family":"Samadian","sequence":"additional","affiliation":[{"name":"Drug and Alcohol Services South Australia SA Health  Adelaide Australia"},{"name":"SA Pharmacy, Statewide Clinical Support Services SA Health  Adelaide Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Altobelli","sequence":"additional","affiliation":[{"name":"Drug and Alcohol Services South Australia SA Health  Adelaide Australia"},{"name":"SA Pharmacy, Statewide Clinical Support Services SA Health  Adelaide Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacinta","family":"Johnson","sequence":"additional","affiliation":[{"name":"UniSA Clinical and Health Sciences University of South Australia  Adelaide Australia"},{"name":"SA Pharmacy, Statewide Clinical Support Services SA Health  Adelaide Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Holmwood","sequence":"additional","affiliation":[{"name":"Drug and Alcohol Services South Australia SA Health  Adelaide Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,2,14]]},"reference":[{"key":"e_1_2_9_2_1","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"2","author":"Mattick RP","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_9_3_1","volume-title":"Opioid therapy: opioid pharmacotherapy: delivery in community pharmacy","author":"Felkai C","year":"2019"},{"key":"e_1_2_9_4_1","volume-title":"National Opioid Pharmacotherapy Statistics Annual Data collection (NOPSAD). Cat. no. PSE 266","author":"Australian Institute of Health and Welfare","year":"2021"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/14659891.2018.1523968"},{"key":"e_1_2_9_6_1","first-page":"1","volume-title":"Position paper: medically assisted treatment for opioid dependence","author":"Alcohol\u2010and\u2010Drug\u2010Foundation","year":"2020"},{"key":"e_1_2_9_7_1","volume-title":"Australian\u2010product\u2010information Buvidal\u00ae weekly (buprenorphine)","author":"TGA","year":"2018"},{"key":"e_1_2_9_8_1","unstructured":"TGA.Australian Product Information \u2010 Sublocade\u00ae Australia: Indivior Pty Ltd;2019.https:\/\/www.ebs.tga.gov.au\/ebs\/picmi\/picmirepository.nsf\/pdf?OpenAgent&id=CP-2019-PI-01756-1&d=20210726172310101."},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2018.1052"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32259-1"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.14636"},{"key":"e_1_2_9_12_1","volume-title":"National guidelines for medication\u2010assisted treatment of opioid dependence","author":"Gowing L","year":"2014"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.3109\/09687639809035769"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/dar.12939"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.14941"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-56703-3_2"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2007.09.007"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp0904813"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.9041"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108959"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13011-022-00474-2"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2022.108781"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2018.06.007"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-7-36"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dev334"},{"key":"e_1_2_9_26_1","volume-title":"Research design: qualitative, quantitative, and mixed methods approaches","author":"Creswell JW","year":"2017"},{"key":"e_1_2_9_27_1","volume-title":"Qualitative research methods","author":"Liamputtong P","year":"2005"},{"key":"e_1_2_9_28_1","volume-title":"Social research methods","author":"Bryman A","year":"2016"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-13-117"},{"key":"e_1_2_9_30_1","volume-title":"Qualitative research practice: a guide for social science students and researchers","author":"Ritchie J","year":"2013"},{"key":"e_1_2_9_31_1","volume-title":"Consumers' experience of the opioid replacement therapy program conducted in the central highlands and Grampians regions of rural Victoria","author":"Vishwanath TP","year":"2018"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1080\/09687630600997527"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2021.2010251"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2013.783567"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2020.05.007"},{"key":"e_1_2_9_36_1","volume-title":"Clinical guidelines for use of depot buprenorphine (Buvidal\u00ae and Sublocade\u00ae) in the treatment of opioid dependence","author":"Lintzeris N","year":"2019"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.737"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2009.10.010"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108486"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1071\/HC20108"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/dar.12979"},{"key":"e_1_2_9_42_1","volume-title":"Submission to: pharmacy remuneration & regulation review","author":"Kelsall J","year":"2016"},{"key":"e_1_2_9_43_1","first-page":"1","article-title":"Opioid pharmacotherapy fees: a long\u2010standing barrier to treatment entry and retention","volume":"8","author":"Lord S","year":"2014","journal-title":"Policy Brief"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.108221"}],"container-title":["Drug and Alcohol Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dar.13616","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/dar.13616","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dar.13616","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:12:07Z","timestamp":1692663127000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dar.13616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,14]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["10.1111\/dar.13616"],"URL":"https:\/\/doi.org\/10.1111\/dar.13616","archive":["Portico"],"relation":{},"ISSN":["0959-5236","1465-3362"],"issn-type":[{"value":"0959-5236","type":"print"},{"value":"1465-3362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,14]]},"assertion":[{"value":"2022-03-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-21","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}